Skip to main content
Risankizumab Shows Long-Term Efficacy in PsA Regardless of Baseline Characteristics
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Risankizumab Shows Long-Term Efficacy in PsA Regardless of Baseline Characteristics
User login
Username
Password
Reset your password
Concept
Lead
score
Psoriatic Arthritis
1
1
Arthritis
0
0.66
Biologic Therapy
0
0.95
Specialty
Lead
score
Rheumatology
1
1
Dermatology
0
0.55
Orthopaedics
0
0.33
Pharmacist
0
0.26
Edit Tags